OptimumBank Holdings, Inc. filings document the regulatory record for a Florida bank holding company that owns OptimumBank, OptimumFunding, LLC and OptimumFinance, LLC. Its 8-K reports cover unaudited operating results, financial condition presentations, Regulation FD disclosures, executive leadership changes, subsidiary formation, and material equity transactions.
Proxy and annual meeting filings document director elections, auditor ratification, shareholder voting results, and amendments to the company's capital structure, including authorization of nonvoting common stock. Other disclosures address exchanges of Series B Convertible Preferred Stock into common stock, governance matters, and the capital and operating structure of the bank and non-bank lending subsidiaries.
OptimumBank Holdings, Inc. reported that, effective October 1, 2025, it adopted articles of amendment to its articles of incorporation to amend and restate the terms of its Series B preferred stock. The change makes the terms of the Series B preferred stock conform, in all material respects, to the company’s Series C preferred stock. The Series B preferred stock will now be included in diluted common shares and in related financial disclosures such as diluted earnings per share, which will affect how future per-share figures are presented. The amended and restated certificate of designation for the Series B preferred stock is included as an exhibit.
OptimumBank Holdings, Inc. filed a current report to note that it issued a press release on August 12, 2025 to clarify a comment made during its second quarter 2025 earnings webcast held on August 7, 2025. The filing states that both the press release and a transcript of the webcast are provided as Exhibit 99.1. The company also explains that this information is being furnished rather than filed, which limits how it is treated for certain securities law liability and incorporation-by-reference purposes.
OptimumBank Holdings, Inc. reported results for the quarter ended June 30, 2025. Total assets increased to $999.1 million from $932.9 million, driven by a rise in cash and cash equivalents to $181.8 million from $93.6 million. Deposits grew to $878.9 million from $772.2 million while net loans declined to $774.5 million from $795.0 million.
Net earnings for the quarter were $3.602 million versus $3.496 million a year earlier and $7.472 million for the six months ended June 30, 2025 versus $5.873 million a year earlier. Net interest income was $10.242 million for the quarter and $19.668 million for six months. Credit loss expense was $1.040 million in the quarter; the allowance for credit losses totaled $9.338 million (1.19% of loans). Accumulated other comprehensive loss includes $7.25 million of unrealized AFS security losses. Regulatory capital remains above well-capitalized thresholds with Tier 1 at 11.89%.
OptimumBank Holdings, Inc. (NYSE American: OPHC) filed Prospectus Supplement No. 1 to its August 20, 2024 at-the-market (ATM) prospectus, updating investors on its common-stock issuance program.
- Amended Sales Agreement: On July 1, 2025, the company added A.G.P./Alliance Global Partners as a second sales agent alongside Compass Point Research & Trading, LLC. Both firms may act as agent or principal under the "Amended Sales Agreement."
- Offering Size: The total ATM capacity remains $25 million. Through June 27, 2025, OPHC has already sold $9,569,512, leaving $15,430,488 available for future issuance.
- Sales Mechanics: • Shares will be sold from time to time by either agent via ordinary-broker transactions or other methods qualifying as Rule 415 "at the market" offerings. • The company may set daily share or dollar limits and minimum acceptable prices. • Either party may suspend or terminate sales at any time.
- Compensation & Costs: Agents earn up to 2.0 % of gross proceeds per share sold and are eligible for reimbursement of out-of-pocket expenses capped at $55,000. All commissions are deemed underwriting discounts; the company provides customary indemnification.
- Settlement & Reporting: Trades settle T+1 through DTC. OPHC will disclose quarterly the number of shares sold, net proceeds and total agent compensation.
- Risk Notice: The supplement re-affirms that investing in OPHC common stock "involves a high degree of risk," directing investors to previously disclosed Risk Factors.
- Trading Snapshot: Last reported share price on June 27, 2025 was $4.51.
In sum, the filing primarily extends distribution capacity by engaging a second agent and confirms the remaining authorization to raise approximately $15.4 million of equity capital, subject to market conditions.